Patterns of Quick-relief and Long-term Controller Medication Use in Pediatric Asthma
Overview
Affiliations
Objectives: To simultaneously examine adherence to long-term controller and quick-relief medications and to contrast patterns of medication use in children with asthma.
Study Design: Cross-sectional, 1-month follow-up study conducted with 75 children ages 8 to 16 years diagnosed with persistent asthma and prescribed quick-relief and long-term controller medications by metered dose inhaler. Participants were a subsample of a larger adherence study. The primary outcome measure was adherence to both medications as measured by electronic monitoring devices. A classification framework for contrasting adherence patterns between medication classes was developed to identify cases for individual analysis.
Results: High levels of nonadherence to long-term controller medications (median = 46% of prescribed doses taken) and variable patterns of quick-relief medication use (range = 0 to 251 doses over the month) were documented, whereas consistent relationships between patterns of medication use across both classes were not found. Individual cases identified by the classification scheme illustrated the complexity and clinical utility of contrasting adherence patterns.
Conclusions: Monitoring long-term controller medication adherence may be more predictive of morbidity than quick-relief medication use, except in outlier cases in which monitoring both medication types may be valuable for clinical and empirical purposes.
eHealth Technologies for Monitoring Pediatric Asthma at Home: Scoping Review.
van der Kamp M, Hengeveld V, Brusse-Keizer M, Thio B, Tabak M J Med Internet Res. 2023; 25:e45896.
PMID: 37477966 PMC: 10403763. DOI: 10.2196/45896.
Impact of caregiver depression on child asthma outcomes in Mexicans and Puerto Ricans.
Kaur K, Arcoleo K, Serebrisky D, Rastogi D, Marsiglia F, Feldman J J Asthma. 2021; 59(11):2246-2257.
PMID: 34793283 PMC: 9534376. DOI: 10.1080/02770903.2021.2008427.
Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors.
Strawn J, Poweleit E, Uppugunduri C, Ramsey L Front Pharmacol. 2021; 12:749692.
PMID: 34658889 PMC: 8517085. DOI: 10.3389/fphar.2021.749692.
Rohan J, Winter M Paediatr Respir Rev. 2021; 39:48-53.
PMID: 34246544 PMC: 8448946. DOI: 10.1016/j.prrv.2021.05.008.
CARE: an observational study of adherence to home nebulizer therapy among children with asthma.
Zhao D, Chen D, Li L, Zou Y, Shang Y, Zhang C Ther Adv Respir Dis. 2021; 15:1753466620986391.
PMID: 33541235 PMC: 7874342. DOI: 10.1177/1753466620986391.